Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study
- Public sites
- 22
- Start date
- Oct 30, 2018
The Center for Valvular Disease provides multidisciplinary care from cardiologists and cardiac surgeons for aortic, mitral and tricuspid valve conditions, including valve repair and replacement. Treatment options include TAVR, traditional and minimally invasive surgery, robotic valve repair, and access to clinical trials and research.
This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
TVMR With the INNOVALVE System Trial - Early Feasibility Study
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Roslyn, NY
Flushing, NY
Bronx, NY